SILO PHARMA ISSUES UPDATE ON MILESTONE ACHIEVEMENTS IN PTSD DRUG DEVELOPMENT AND NEW DIGITAL ASSETS TREASURY PROGRAM
SILO PHARMA INC - PREPARATION FOR FDA IND APPLICATION TO COMMENCE BEFORE YEAR-END
Source text: ID:nGNX6hrXkH
Further company coverage: SILO.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.